Pfizer (PFE) Preferred Shares (2009 - 2020)

Pfizer (PFE) has 12 years of Preferred Shares data on file, last reported at $17.0 million in Q1 2020.

• Preferred Shares for Q1 2020 came in at $17.0 million, down 10.53% year-over-year; the trailing twelve-month figure through Mar 2020 was $17.0 million (down 10.53% YoY), and the FY2019 annual result was $17.0 million, down 10.53% from the prior year.
• Preferred Shares steadied at $17.0 million in Q1 2020 per PFE's latest filing, from $17.0 million in the prior quarter.
• Over five years, Preferred Shares peaked at $26.0 million in Q2 2016 and troughed at $17.0 million in Q4 2019.
• A 5-year average of $21.1 million and a median of $21.0 million in 2017 frame the typical range for Preferred Shares.
• The sharpest annual moves came in 2016 and 2018: Preferred Shares fell 7.14% in 2016, then fell 13.04% in 2018.
• A 5-year view of Preferred Shares shows it stood at $24.0 million in 2016, then fell by 12.5% to $21.0 million in 2017, then declined by 9.52% to $19.0 million in 2018, then decreased by 10.53% to $17.0 million in 2019, then changed by 0.0% to $17.0 million in 2020.
• Business Quant data shows PFE's Preferred Shares at $17.0 million in Q1 2020, $17.0 million in Q4 2019, and $18.0 million in Q3 2019.